Table 1. Widely accepted classifications of BC based on molecular phenotypes.
UNC | MDA | Lund | TCGA | Broad |
---|---|---|---|---|
Basal | Basal | UroA | Cluster I | Basal |
Luminal | Luminal | UroB | Cluster II | Luminal |
Claudin-low | P53-like | GU | Cluster III | Luminal immune |
SCCL | Cluster IV | Immune undifferentiated | ||
Infiltrated |
BC, bladder cancer; UNC, the University of North Carolina; MDA, MD Anderson Cancer Center; Lund, Lund University; TCGA, The Cancer Genome Atlas; Broad, Broad Institute of Massachusetts Institute of Technology and Harvard University; UroA, urobasal A; UroB, urobasal B; GU, genomically unstable; SCCL, squamous cell carcinoma like.